IGFBP7 and acute kidney injury: Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulin-like growthfactor-binding protein 7 (IGFBP7) have gained recognition as clinical biomarkers of AKI, collectively known as NephrocheckTM commercially (79).